Literature DB >> 8686111

Transverse myelitis: a complication of systemic lupus erythematosus that is associated with the antiphospholipid syndrome.

A E Smyth1, I N Bruce, S A McMillan, A L Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8686111      PMCID： PMC2448735     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  11 in total

1.  A "primary" antiphospholipid syndrome?

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

2.  Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients.

Authors:  D Alarcón-Segovia; M Delezé; C V Oria; J Sánchez-Guerrero; L Gómez-Pacheco; J Cabiedes; L Fernández; S Ponce de León
Journal:  Medicine (Baltimore)       Date:  1989-11       Impact factor: 1.889

3.  Transverse myelitis in systemic lupus erythematosus: two cases with magnetic resonance imaging.

Authors:  C P Simeon-Aznar; C Tolosa-Vilella; R Cuenca-Luque; R Jordana-Comajuncosa; J Ordi-Ros; J A Bosch-Gil
Journal:  Br J Rheumatol       Date:  1992-08

Review 4.  The Michael Mason Prize Essay (1994). Antiphospholipid antibodies and disease.

Authors:  C G Mackworth-Young
Journal:  Br J Rheumatol       Date:  1995-11

Review 5.  The antiphospholipid syndrome: ten years on.

Authors:  G R Hughes
Journal:  Lancet       Date:  1993-08-07       Impact factor: 79.321

Review 6.  Diagnosis of antiphospholipid antibodies.

Authors:  M Petri
Journal:  Rheum Dis Clin North Am       Date:  1994-05       Impact factor: 2.670

7.  Transverse myelopathy in systemic lupus erythematosus. Report of three cases and review of the literature.

Authors:  A A Andrianakos; J Duffy; M Suzuki; J T Sharp
Journal:  Ann Intern Med       Date:  1975-11       Impact factor: 25.391

Review 8.  Acute transverse myelopathy complicating systemic lupus erythematosus.

Authors:  D J Propper; R C Bucknall
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

9.  Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Authors:  R H Derksen; P G de Groot; L Kater; H K Nieuwenhuis
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

10.  The management of thrombosis in the antiphospholipid-antibody syndrome.

Authors:  M A Khamashta; M J Cuadrado; F Mujic; N A Taub; B J Hunt; G R Hughes
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245
View more
  6 in total

Review 1.  Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.

Authors:  B Kovacs; T L Lafferty; L H Brent; R J DeHoratius
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

Review 2.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

Review 3.  Demyelination in rheumatic diseases.

Authors:  A Theodoridou; L Settas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

4.  A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation.

Authors:  Asli Kurne; Ilksen Colpak Isikay; Kader Karlioguz; Umut Kalyoncu; Omer Faruk Aydin; Meral Calguneri; Rana Karabudak
Journal:  J Neurol       Date:  2009-01-21       Impact factor: 4.849

Review 5.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

6.  Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review.

Authors:  Rory C Monahan; Hannelore J L Beaart; Rolf Fronczek; Gisela M Terwindt; Liesbeth J J Beaart-van de Voorde; Jeroen de Bresser; Margreet Kloppenburg; Nic J A van der Wee; Tom W J Huizinga; Gerda M Steup-Beekman
Journal:  Neuropsychiatr Dis Treat       Date:  2020-12-22       Impact factor: 2.570
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.